Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2009
08/04/2009US7569588 Biphenyl compounds useful as muscarinic receptor antagonists
08/04/2009US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease
08/04/2009US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same
08/04/2009US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome
08/04/2009US7569578 Heterocyclic anti-migraine agents
08/04/2009US7569577 (2S)-1-[4-({4-[3-chloro-2-fluoroanilino]-6-methoxyquinazolin-7-yl}oxy)piperidin-1-yl]-1-oxopropan-2-ol; antiproliferative agents; for treatment of cancers mediated by erbB receptor EGFR tyrosine kinases; psoriasis
08/04/2009US7569568 1-[5-(5-tert-Butyl-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; inflammation, chronic inflammatory disease
08/04/2009US7569566 Inhibitors of tyrosine kinases
08/04/2009US7569516 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives
08/04/2009US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease
08/04/2009CA2425984C 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their preparation processes and uses
08/04/2009CA2334727C Tetrahydroquinoline derivatives as glycine antagonists
07/2009
07/30/2009WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides
07/30/2009WO2009094427A1 4-pyridinone compounds and their use for cancer
07/30/2009WO2009094417A1 4-pyridinone compounds and their use for cancer
07/30/2009WO2009093981A1 Triazine compounds as kinase inhibitors
07/30/2009WO2009093049A1 Fused pyridines active as inhibitors of c-met
07/30/2009WO2009093032A1 Phthalazinone derivatives
07/30/2009WO2009093012A1 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity
07/30/2009WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009WO2009092301A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
07/30/2009WO2009092295A1 A set of geldanamycin derivatives and their preparation methods
07/30/2009WO2009092293A1 Pyrollidine-based compounds
07/30/2009WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof
07/30/2009WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation
07/30/2009WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
07/30/2009WO2009018925A8 Herbicide triazolylpyridine ketones
07/30/2009WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof
07/30/2009US20090192314 Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
07/30/2009US20090192196 Fungicide hydroximoyl-tetrazole derivatives
07/30/2009US20090192195 Compounds Having CRTH2 Antagonist Activity
07/30/2009US20090192194 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them
07/30/2009US20090192193 Diagnostic agent and method for detection of cancer and a means for treatment of same
07/30/2009US20090192191 Substituted hydroxamic acid derivatives as tnf inhibitors
07/30/2009US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors
07/30/2009US20090192169 Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
07/30/2009US20090192168 Compounds, Compositions and Methods
07/30/2009US20090192164 Treating agent of inflammatory bowel disease
07/30/2009US20090192160 Compounds
07/30/2009US20090192156 Phthalazinone derivatives
07/30/2009US20090192148 Organic Compounds
07/30/2009US20090192141 Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
07/30/2009US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
07/30/2009US20090191426 Organic compound, charge-transporting material, and organic electroluminescent element
07/30/2009US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process
07/30/2009US20090189518 Fused polycyclic compounds and organic light-emitting device using the same
07/30/2009US20090189119 Use of metal complex compounds comprising pyridine pyrimidine or s-triazine derived ligands as catalysts for oxidations with organic peroxy acids and/or precursors of organic peroxy acids and h202
07/30/2009CA2713997A1 New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof
07/30/2009CA2713111A1 4-pyridinone compounds and their use for cancer
07/30/2009CA2712998A1 Beta-amino acid derivatives for treatment of diabetes
07/30/2009CA2712959A1 Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
07/30/2009CA2712791A1 Fused pyridines active as inhibitors of c-met
07/30/2009CA2712777A1 5-fluoro pyrimidine derivatives as fungicides
07/30/2009CA2712619A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof
07/30/2009CA2708175A1 Phthalazinone derivatives
07/29/2009EP2083014A2 Inhibitors of interleukin-1ß converting enzyme
07/29/2009EP2081924A2 Small molecule inhibitors of toll-like receptor 9
07/29/2009EP2081923A1 Certain substituted amides, method of making, and method of use thereof
07/29/2009EP2081922A2 5,6-ring annulated indole derivatives and use thereof
07/29/2009EP2081921A1 Short-acting benzodiazepine salts and their polymorphic forms
07/29/2009EP2081903A2 2-aminocarbonyl-pyridine derivatives
07/29/2009EP2081894A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
07/29/2009EP2081892A1 Compounds and methods for treating protein folding disorders
07/29/2009EP2081891A2 Pharmaceutical compounds having hsp90 inhibitory or modulating activity
07/29/2009EP2081572A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
07/29/2009EP1979321B1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
07/29/2009EP1926712B1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
07/29/2009EP1807407B1 Aromatic amides as inhibitors of c-fms kinase
07/29/2009EP1753748B1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
07/29/2009EP1740571B1 A process for preparing pyridinylmethyl-1h- benzimidazole compounds in enantiomerically enriched form or as single enantiomers
07/29/2009EP1732917B1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
07/29/2009EP1701944B1 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
07/29/2009EP1686119B1 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
07/29/2009EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
07/29/2009EP1409468B9 Guanidinobenzamides as mc4-r agonists
07/29/2009EP1261601B1 Substituted indoles for modulating nfkb activity
07/29/2009CN101495470A 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of CNS disorders
07/29/2009CN101495469A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives as antagonist of TRPV1 or VR1 receptor, preparation thereof and therapeutic use thereof
07/29/2009CN101495468A Inhibitors of plasma kallikrein
07/29/2009CN101492416A Compounds effecting glucokinase
07/29/2009CN101492383A Process for making chiral 1,4-disubstituted piperazines
07/29/2009CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities
07/29/2009CN100519554C CCR5 antagonists for treating aids
07/29/2009CN100519552C Pyrazole compounds
07/29/2009CN100519551C Anthranilamide-based compound, method for producing the same, and pest-controlling agent containing the same
07/29/2009CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3
07/29/2009CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds
07/29/2009CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors
07/29/2009CN100519528C Compounds with analgesic effect
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/29/2009CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists
07/28/2009US7567371 Electrochromic compounds
07/28/2009US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis
07/28/2009US7566734 Imidazolyl derivatives
07/28/2009US7566732 5-(1H-benzimidazol-2-ylmethylene)-3-(4-fluorophenyl)-2-thioxo-1,3-thiazolidin-4-one; ubiquitin ligase (synthetase) inhibitors; inhibit ubiquitination of target proteins; poxviruses; herpesviruses; retroviruses; variola viruses; smallpox; hemorrhagic smallpox; HIV; vaccines; side effect reduction
07/28/2009US7566730 Substituted aminoethers for the treatment of Alzheimer's disease
07/28/2009US7566728 Advance circadian rhythm disorders; using opioid receptor antagonist
07/28/2009US7566723 1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use
07/28/2009US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
07/28/2009US7566718 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity